220 related articles for article (PubMed ID: 15273840)
21. Magnetic resonance imaging of intracavernous pathology.
Komiyama M; Hakuba A; Yasui T; Yagura H; Fu Y; Baba M; Nishimura S
Neurol Med Chir (Tokyo); 1989 Jul; 29(7):573-8. PubMed ID: 2477754
[TBL] [Abstract][Full Text] [Related]
22. Cavernous Sinus Invasion in Pituitary Adenomas: Systematic Review and Pooled Data Meta-Analysis of Radiologic Criteria and Comparison of Endoscopic and Microscopic Surgery.
Dhandapani S; Singh H; Negm HM; Cohen S; Anand VK; Schwartz TH
World Neurosurg; 2016 Dec; 96():36-46. PubMed ID: 27591098
[TBL] [Abstract][Full Text] [Related]
23. Magnetic resonance imaging criteria to predict complete excision of parasellar pituitary macroadenoma on postoperative imaging.
Connor SE; Wilson F; Hogarth K
J Neurol Surg B Skull Base; 2014 Feb; 75(1):41-6. PubMed ID: 24498588
[TBL] [Abstract][Full Text] [Related]
24. Preoperative depiction of cavernous sinus invasion by pituitary macroadenoma using three-dimensional anisotropy contrast periodically rotated overlapping parallel lines with enhanced reconstruction imaging on a 3-tesla system.
Yoneoka Y; Watanabe N; Matsuzawa H; Tsumanuma I; Ueki S; Nakada T; Fujii Y
J Neurosurg; 2008 Jan; 108(1):37-41. PubMed ID: 18173308
[TBL] [Abstract][Full Text] [Related]
25. Cavernous sinus invasion by pituitary adenomas--relationship between magnetic resonance imaging findings and histologically verified dural invasion.
Daita G; Yonemasu Y; Nakai H; Takei H; Ogawa K
Neurol Med Chir (Tokyo); 1995 Jan; 35(1):17-21. PubMed ID: 7700477
[TBL] [Abstract][Full Text] [Related]
26. Extension Pathways of Pituitary Adenomas with Cavernous Sinus Involvement and Its Surgical Approaches.
Ceylan S; Anik I; Cabuk B; Caklili M; Anik Y
World Neurosurg; 2019 Jul; 127():e986-e995. PubMed ID: 30965171
[TBL] [Abstract][Full Text] [Related]
27. Pre-operative MRI predictors of hormonal remission status post pituitary adenoma resection.
Braileanu M; Hu R; Hoch MJ; Mullins ME; Ioachimescu AG; Oyesiku NM; Pappy A; Saindane AM
Clin Imaging; 2019; 55():29-34. PubMed ID: 30731423
[TBL] [Abstract][Full Text] [Related]
28. MRI of growth hormone-secreting pituitary adenomas: factors determining pretreatment hormone levels.
Saeki N; Iuchi T; Isono S; Eda M; Yamaura A
Neuroradiology; 1999 Oct; 41(10):765-71. PubMed ID: 10552028
[TBL] [Abstract][Full Text] [Related]
29. Prediction of cavernous sinus invasion in patients with Cushing's disease by magnetic resonance imaging.
Mastorakos P; Taylor DG; Chen CJ; Buell T; Donahue JH; Jane JA
J Neurosurg; 2018 Jul; 130(5):1593-1598. PubMed ID: 29979125
[TBL] [Abstract][Full Text] [Related]
30. Magnetic resonance imaging and biological markers in pituitary adenomas with invasion of the cavernous sinus space.
Pan LX; Chen ZP; Liu YS; Zhao JH
J Neurooncol; 2005 Aug; 74(1):71-6. PubMed ID: 16078111
[TBL] [Abstract][Full Text] [Related]
31. Preoperative prediction of cavernous sinus invasion by pituitary adenomas using a radiomics method based on magnetic resonance images.
Niu J; Zhang S; Ma S; Diao J; Zhou W; Tian J; Zang Y; Jia W
Eur Radiol; 2019 Mar; 29(3):1625-1634. PubMed ID: 30255254
[TBL] [Abstract][Full Text] [Related]
32. Endoscopic endonasal surgery for nonadenomatous, nonmeningeal pathology involving the cavernous sinus.
Patrona A; Patel KS; Bander ED; Mehta A; Tsiouris AJ; Anand VK; Schwartz TH
J Neurosurg; 2017 Mar; 126(3):880-888. PubMed ID: 27128582
[TBL] [Abstract][Full Text] [Related]
33. Cavernous sinus invasion by pituitary adenomas.
Ahmadi J; North CM; Segall HD; Zee CS; Weiss MH
AJR Am J Roentgenol; 1986 Feb; 146(2):257-62. PubMed ID: 3484572
[TBL] [Abstract][Full Text] [Related]
34. [Imaging of tumors of the pituitary gland].
Trattnig S; Ba-Ssalamah A; Pinker K; Nöbauer-Huhmann I; Wolfsberger S; Knosp E
Wien Klin Wochenschr; 2003; 115 Suppl 2():23-7. PubMed ID: 15518142
[TBL] [Abstract][Full Text] [Related]
35. [Intracavernous extension of hypophyseal macroadenomas: infiltration or invagination?].
Roux FX; Obreja C; Moussa R; Devaux B; Nataf F; Turak B; Page P; Meder JF
Neurochirurgie; 1998 Dec; 44(5):344-51. PubMed ID: 9915015
[TBL] [Abstract][Full Text] [Related]
36. [Performance of Knosp grade for cavernous sinus invasion of Cushing's disease].
Xu XY; Wang RZ
Zhonghua Yi Xue Za Zhi; 2019 Jan; 99(5):388-390. PubMed ID: 30772983
[No Abstract] [Full Text] [Related]
37. Surgical outcomes using a medial-to-lateral endonasal endoscopic approach to pituitary adenomas invading the cavernous sinus.
Woodworth GF; Patel KS; Shin B; Burkhardt JK; Tsiouris AJ; McCoul ED; Anand VK; Schwartz TH
J Neurosurg; 2014 May; 120(5):1086-94. PubMed ID: 24527820
[TBL] [Abstract][Full Text] [Related]
38. Endoscopic endonasal transsellar approach for laterally extended pituitary adenomas: volumetric analysis of cavernous sinus invasion.
Taniguchi M; Hosoda K; Akutsu N; Takahashi Y; Kohmura E
Pituitary; 2015 Aug; 18(4):518-24. PubMed ID: 25261331
[TBL] [Abstract][Full Text] [Related]
39. Intracavernous sinus ectopic adrenocorticotropin-secreting tumours causing therapeutic failure in transsphenoidal surgery for Cushing's disease.
Ohnishi T; Arita N; Yoshimine T; Mori S
Acta Neurochir (Wien); 2000; 142(8):855-64. PubMed ID: 11086823
[TBL] [Abstract][Full Text] [Related]
40. Interrater and intrarater reliability of the Knosp scale for pituitary adenoma grading.
Mooney MA; Hardesty DA; Sheehy JP; Bird R; Chapple K; White WL; Little AS
J Neurosurg; 2017 May; 126(5):1714-1719. PubMed ID: 27367241
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
